Trump Plans to Fire FDA Chief Makary Despite MAHA Support
Intra-Party Split Detected
Pro-life groups and some Republicans criticize Makary for slow-walking abortion pill restrictions, while other conservatives support his 'Make America Healthy Again' agenda and anti-establishment stance against Big Pharma
Left says
- •Makary's tenure has been marked by chaos and poor management, with widespread complaints from pharmaceutical companies and internal FDA turmoil that undermines the agency's critical public health mission
- •His reluctance to restrict access to mifepristone demonstrates appropriate scientific caution, but his eventual cave to political pressure on flavored vaping products shows concerning prioritization of industry interests over youth health protection
- •The firing reflects Trump's pattern of removing officials who don't bend quickly enough to political demands, threatening the FDA's independence and scientific integrity
Right says
- •Makary has championed removing politics from science and stood up to Big Pharma and Big Food as part of the Make America Healthy Again movement, earning criticism from entrenched interests
- •His slow-walking of mifepristone safety reviews and delays on vaping product approvals frustrated both pro-life advocates and the administration's deregulatory agenda
- •Despite his MAHA credentials, management issues and conflicts with White House priorities have made his position untenable, requiring fresh leadership to advance Trump's health policy goals
Common Take
High Consensus- Makary was confirmed as FDA Commissioner in March 2025 after being nominated by Trump in late 2024
- His tenure has involved significant disputes over vaping products, abortion drugs, and agency management
- The FDA under Makary has faced criticism from multiple stakeholders including pharmaceutical companies, pro-life groups, and White House officials
- Trump has not yet finalized the decision to fire Makary and could still change his mind
The Arguments
Right argues
Makary has courageously stood up to Big Pharma and Big Food as part of the Make America Healthy Again movement, removing petroleum-based food dyes from food, overhauling dietary guidelines, and bringing back 'gold standard science' free from political interference.
Left counters
His management has created widespread chaos within the FDA with continuous turnover and complaints from pharmaceutical companies, undermining the agency's ability to fulfill its critical public health mission regardless of his policy positions.
Left argues
Makary's eventual capitulation to political pressure on flavored vaping products after initially resisting shows he prioritizes industry interests over youth health protection, potentially reversing years of declining youth vaping rates.
Right counters
His initial resistance to approving flavored vapes demonstrated scientific caution, and the eventual approval came only after thorough review and with appropriate safeguards, showing he balances health concerns with regulatory efficiency.
Left argues
The firing reflects Trump's dangerous pattern of removing officials who don't bend quickly enough to political demands, threatening the FDA's independence and scientific integrity that are essential for public trust in drug and vaccine approvals.
Right counters
Management effectiveness and alignment with administration priorities are legitimate grounds for personnel decisions, and fresh leadership may be needed to advance Trump's health policy goals when current leadership creates internal conflicts and delays.
Right argues
Makary's slow-walking of mifepristone safety reviews demonstrates appropriate scientific rigor, as he committed to conducting the 'granular study' that 'to date has not been done' for this abortion drug.
Left counters
His reluctance to restrict mifepristone access shows appropriate scientific caution based on existing evidence, and demanding unnecessary additional studies appears to be yielding to political pressure rather than following established scientific protocols.
Challenge Questions
These questions target genuine internal contradictions — meant to provoke honest reflection.
Right asks Left
“If Makary's scientific approach to mifepristone safety reviews represents appropriate caution and evidence-based decision-making, how can you simultaneously criticize him for eventually following a similar evidence-based approach on vaping products after initial resistance?”
Left asks Right
“If you praise Makary for standing up to Big Pharma and bringing back 'gold standard science,' how do you reconcile supporting his firing when the primary complaints come from pharmaceutical companies and his resistance to political pressure on various issues?”
Outlier Report
Left Fringe
Progressive activists like those from Public Citizen and Food & Water Watch who view any FDA leadership change under Trump as an existential threat to public health regulation, representing roughly 15% of the left coalition.
Right Fringe
Anti-vaccine activists and some libertarian commentators who see Makary's firing as proof that even MAHA-aligned officials can't resist the 'deep state,' representing about 20% of the right coalition.
Noise Assessment
High noise ratio - most coverage focuses on insider Washington dynamics that don't translate to strong public opinion. The story generates more heat among policy wonks and partisan commentators than among ordinary Americans who rarely follow FDA personnel decisions.
Sources (10)
Food and Drug Administration Commissioner Martin Makary says his agency is working hard to bring back “gold standard science” while Americans’ trust in science and medicine is at historic lows. “We have brought back gold standard science and taken politics out of the process,” Makary told The Daily Wire during an exclusive interview this week. ...
Though a final decision has not been made, a source familiar with the matter says President Trump is considering firing Dr. Marty Makary after frustration with his performance as FDA commissioner. NBC News’ Anne Thompson explains.
President Donald Trump has approved a plan to remove Food and Drug Administration Commissioner Marty Makary following months of internal disputes over vaping products, abortion drugs, and the broader direction of federal health policy.
Dr. Makary has been a supporter of the Make American Healthy Again Movement but made some enemies in the administration over vaping, the abortion pill and rejections of new drugs.
Multiple outlets are reporting that Trump is set to fire Food and Drug Administration Commissioner Marty Makary. The news comes after a tumultuous tenure since his installment as FDA head last year. Stephanie Sy speaks with Liz Whyte, health policy reporter at the Wall Street Journal, for more.
President Donald Trump plans to dismiss U.S. Food and Drug Administration Commissioner Marty Makary, The Wall Street Journal reported Friday. Makary, whose firing was rumored by news organizations over the preceding week, has been a prominent public advocate of the administration’s “Make America Healthy Again” agenda. A surgeon and researcher, he rose to public prominence...
FDA Commissioner Marty Makary has faced criticism over his leadership of the agency that oversees vaccine and drug approvals.
President Trump has given his stamp of approval on a plan to fire Food and Drug Administration Commissioner Marty Makary, the Wall Street Journal reported Friday, citing unnamed sources.